Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.42 |
| ▸ | CA2 | P00918 | 4/20 | 0.42 |
| ▸ | CA4 | P22748 | 4/20 | 0.42 |
| ▸ | CA6 | P23280 | 4/20 | 0.42 |
| ▸ | CA5A | P35218 | 4/20 | 0.42 |
| ▸ | CA7 | P43166 | 4/20 | 0.42 |
| ▸ | CA9 | Q16790 | 4/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA3 | P07451 | 3/20 | 0.42 |
| ▸ | F13A1 | P00488 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | THPO | P40225 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8699215 | 0.93 | CA12 (0.40) | CA12CA2CA4CA6CA5A | |
| SCHEMBL20362314 | 0.90 | CA12 (0.38) | CA12CA2CA4CA6CA5A | |
| SCHEMBL11184192 | 0.90 | CA12 (0.38) | CA12CA2CA4CA6CA5A | |
| SCHEMBL27345554 | 0.87 | DNM1 (0.48) | TSHRMEN1KMT2ADNM1 | |
| SCHEMBL27322919 | 0.87 | DNM1 (0.42) | CA12CA2CA4CA6CA5A | |
| SCHEMBL22205253 | 0.85 | DNM1 (0.46) | TSHRMEN1KMT2ADNM1 | |
| SCHEMBL8496424 | 0.84 | CASP2 (0.33) | CA12CA2CA4CA6CA5A | |
| Ammonia Solution, Strong SCHEMBL9525661 | 0.82 | SIGMAR1 (0.37) | CA12CA2CA4CA6CA5A | |
| SCHEMBL9171472 | 0.82 | DNM1 (0.48) | TSHRMEN1KMT2ADNM1 | |
| SCHEMBL27603365 | 0.82 | DNM1 (0.48) | TSHRMEN1KMT2ADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2638003-B1 | TRANSAMINATION OF NITROGEN-CONTAINING COMPOUNDS TO HIGH MOLECULAR WEIGHT POLYALKYLENEAMINES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-11-20 | — | — | EP | disclosed |
| US-9000217-B2 | Transamination of nitrogen-containing compounds to high molecular weight polyalkyleneamines | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-04-07 | — | — | US | disclosed |
| EP-2638003-A1 | TRANSAMINATION OF NITROGEN-CONTAINING COMPOUNDS TO HIGH MOLECULAR WEIGHT POLYALKYLENEAMINES | Dow Global Technologies LLC (US) | 2013-09-18 | — | — | EP | disclosed |
| US-20130225864-A1 | TRANSAMINATION OF NITROGEN-CONTAINING COMPOUNDS TO HIGH MOLECULAR WEIGHT POLYALKYLENEAMINES | DOW GLOBAL TECHNOLOGIES LLC | 2013-08-29 | — | — | US | disclosed |
| WO-2012064484-A1 | TRANSAMINATION OF NITROGEN-CONTAINING COMPOUNDS TO HIGH MOLECULAR WEIGHT POLYALKYLENEAMINES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225864-A1 | TRANSAMINATION OF NITROGEN-CONTAINING COMPOUNDS TO HIGH MOLECULAR WEIGHT POLYALKYLENEAMINES | PARG, PNMT, HNMT | CA12 1984/4885CA2 3181/4885CA4 1605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.